title: Anti-GP 120 antibodies from HIV seropositive individuals mediate broadly reactive anti-HIV ADCC.
abstract: Cytophilic antibodies which mediate antibody dependent cellular cytotoxicity (ADCC) against envelope antigens of human immunodeficiency virus (HIV) can be found in seropositive individuals. In these experiments, sera from a wide spectrum of HIV infected patients ranging from asymptomatic to overt acquired immunodeficiency syndrome (AIDS) were shown to contain high titers of antibodies that mediate ADCC. Not only did patient antibodies bind to surface expressed viral antigens and mediate ADCC against cells chronically infected with human T-lymphotropic virus type IIIB (HTLV-IIIB), but also against cells infected with the divergent HTLV-IIIRF2 and HTLV-IIIMN viral isolates. Similar results were obtained with target cells bearing purified GP 120 from HTLV-IIIB and HTLV-IIIRF2, indicating that a major portion of the activity was mediated by anti-GP 120 antibodies. Consistent with this was the ability to absorb most of the group-specific ADCC activity from the serum of an HIV infected individual using affinity columns bearing purified HTLV-IIIB GP 120. The finding that human antibodies reactive against the HIV envelope glycoprotein mediate ADCC against cells chronically infected with divergent strains of HIV will have important implications in designing rational approaches to passive and active immunotherapy.
authors.affiliation: Department of Surgery, Duke University Medical Center, Durham, NC 27710.
authors.forename: H K
authors.initials: HK
authors.lastname: Lyerly
authors.forename: D L
authors.initials: DL
authors.lastname: Reed
authors.forename: T J
authors.initials: TJ
authors.lastname: Matthews
authors.forename: A J
authors.initials: AJ
authors.lastname: Langlois
authors.forename: P A
authors.initials: PA
authors.lastname: Ahearne
authors.forename: S R
authors.initials: SR
authors.lastname: Petteway
authors.forename: K J
authors.initials: KJ
authors.lastname: Weinhold
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology*; D000914:Antibodies, Viral / Q000032:analysis* / Q000276:immunology; D000920:Antibody-Dependent Cell Cytotoxicity; D002460:Cell Line; D005434:Flow Cytometry; D006678:HIV / Q000276:immunology*; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D006679:HIV Seropositivity; D006801:Humans; D009500:Neutralization Tests; D012191:Retroviridae Proteins / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; D012191:Retroviridae Proteins; D014759:Viral Envelope Proteins